Thematic photoMartin FalbisonerCC BY-SA 3.0Resized, encoded as WebP; displayed with responsive cropping under the original licenceSEC EDGAR published this disclosure on 2026-08-14. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0000907654-26-000075
acquired disposedD
codeS
direct or indirectD
form4
is derivativefalse
issuer nameOruka Therapeutics, Inc.
labelOpen market sale
Source record & verificationDates, provenance and technical details
Context
links are based on the recorded entity typeRecorded payloadStructured source data
Recorded payload
JSON payload as stored after parsing{
"accession": "0000907654-26-000075",
"acquired_disposed": "D",
"code": "S",
"direct_or_indirect": "D",
"form": "4",
"is_derivative": false,
"issuer_name": "Oruka Therapeutics, Inc.",
"label": "Open market sale",
"person_name": "Agarwal Arjun",
"price": 105.5716,
"role": "Senior Vice President, Finance",
"security": "Common Stock",
"shares": 2132,
"shares_owned_after": 21080,
"source_path": "edgar/data/2033974/0000907654-26-000075.txt",
"ticker": "ORKA",
"transaction_date": "2026-08-13",
"value": 225078.6512
}Evidence-based analysis
facts, provenance and explicit model coverageDescriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.